Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Dr. Reddy’s and GSK Form Alliance in Emerging Markets
6:11 AM MDT | June 29, 2009 | DEEPTI RAMESH
Dr. Reddy’s Laboratories (Hyderabad, India) says it has entered into an agreement with GlaxoSmithKline (GSK; London) to develop and market select products in several emerging markets, excluding India. Financial terms of the deal were not disclosed. Hussain: Demand for drugs rising in some regions. Dr. Reddy’s says this is the first such alliance between the two companies. The deal calls for GSK to gain exclusive access to Dr. Reddy’s portfolio and future pipeline of more than 100 branded pharmaceuticals in fast-growing therapeutic segments such...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee